Position history for Avoro Capital Advisors LLC's holdings in APELLIS PHARMACEUTICALS INC
Avoro Capital Advisors LLC holds 12.2M shares of APLS (APELLIS PHARMACEUTICALS INC), worth $491.7M as of 2026-Q1. APLS represents 4.8% of Avoro Capital Advisors LLC's portfolio.
Current Value
$491.7M
Current Shares
12.2M
Total Value Change
+$65.5M
Total Shares Change
+1.1M
Other major holders of APLS: UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC, BANQUE PICTET & CIE SA
Unchanged |
| 12.2M |
0.0% |
| $491.7M |
| 4.8% |
| $20.16 |
0 |
| 2025-Q4 | Unchanged | 12.2M | 0.0% | $307M | 3.0% | $25.24 | 0 |
| 2025-Q3 | Unchanged | 12.2M | 0.0% | $276.6M | 3.6% | $22.65 | 0 |
| 2025-Q2 | Unchanged | 12.2M | 0.0% | $211.6M | 3.7% | $17.43 | 0 |
| 2025-Q1 | Unchanged | 12.2M | 0.0% | $267.3M | 4.2% | $24.27 | 0 |
| 2024-Q4 | Increased | 12.2M | +10.0% | $390M | 5.5% | $31.90 | 68 |
| 2024-Q3 | Unchanged | 11.1M | 0.0% | $320.4M | 4.7% | $29.47 | 0 |
| 2024-Q2 | Unchanged | 11.1M | 0.0% | $426.2M | 5.7% | $38.36 | 0 |